Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
89bio | ETNB | 3. mai 2024 | 9.22 | +4.06 |
Aligos Therapeutics | ALGS | 3. mai 2024 | 0.81 | -4.24 |
ALX Oncology | ALXO | 3. mai 2024 | 15.36 | -7.58 |
Annexon | ANNX | 3. mai 2024 | 4.88 | +4.72 |
BioVie | BIVI | 3. mai 2024 | 0.49 | -1.90 |
Cerevel Therapeutics | CERE | 3. mai 2024 | 42.55 | -0.09 |
Chromadex | CDXC | 3. mai 2024 | 3.78 | +0.53 |
Dyne Therapeutics | DYN | 3. mai 2024 | 26.08 | +0.31 |
Exicure | XCUR | 3. mai 2024 | 0.50 | 0.00 |
Fusion Pharmaceuticals | FUSN | 3. mai 2024 | 21.45 | -0.19 |
Galapagos ADR | GLPG | 3. mai 2024 | 29.09 | -1.22 |
Generation Bio | GBIO | 3. mai 2024 | 3.17 | +1.93 |
Greenwich LifeSciences | GLSI | 3. mai 2024 | 14.39 | +2.86 |
Inhibrx | INBX | 3. mai 2024 | 34.15 | +0.41 |
Inozyme Pharma | INZY | 3. mai 2024 | 4.74 | +1.94 |
Inventiva ADR | IVA | 3. mai 2024 | 3.30 | +3.13 |
iTeos Therapeutics | ITOS | 3. mai 2024 | 11.66 | +1.48 |
Keros Therapeutics | KROS | 3. mai 2024 | 60.57 | +6.08 |
Kintara Therapeutics | KTRA | 3. mai 2024 | 0.15 | -3.75 |
Kronos Bio | KRON | 3. mai 2024 | 1.02 | -0.97 |
Kymera Therapeutics | KYMR | 3. mai 2024 | 37.40 | +3.03 |
Legend Biotech ADR | LEGN | 3. mai 2024 | 45.41 | -1.13 |
Lyra Therapeutics | LYRA | 3. mai 2024 | 4.03 | -12.96 |
Nautilus Biotechnology | NAUT | 3. mai 2024 | 2.69 | +0.75 |
Nurix Therapeutics | NRIX | 3. mai 2024 | 12.78 | +0.39 |
Nuvation Bio A | NUVB | 3. mai 2024 | 3.22 | -1.53 |
Oric Pharmaceuticals | ORIC | 3. mai 2024 | 9.71 | +2.00 |
PMV Pharmaceuticals | PMVP | 3. mai 2024 | 1.99 | +6.42 |
Poseida Therapeutics | PSTX | 3. mai 2024 | 2.87 | +2.87 |
Prelude Therapeutics | PRLD | 3. mai 2024 | 3.86 | -3.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.